Radio Feature 26: Christof Schmidhuber in conversation with Sona Blessing
Wednesday, August 31, 2011
Christof Schmidhuber, is a partner at Syndex Capital Management.
Formerly he was Global Head of Hedge Fund Risk Management at Credit Suisse and a member of the investment committee. He and his teams in Zurich and New York were responsible for operational due diligence and market risk monitoring of several hundred hedge fund managers, and of multi-manager portfolios with AuM exceeding USD20 billion.
In this radio feature he elaborates on how and why Syndex replication is different and how it can be integrated into an asset allocation mandate
Download this feature as MP3 (11.55 MB)
Listen to the complete feature
Or listen to selected sub-features
So Christof, what is special about Syndex replication?
How has the Global Syndex performed (a) in general, and (b) through August 2011?
What lessons have you learnt from the market melt-down in August 2011?
Are there hedge fund strategies that cannot be replicated?
What are the risks of replication?
Inherent model risk, other systematic model related risk (i.e. the summer of 2007), confined universe?
How scalable is the strategy?
How can investors integrate your process into their asset allocation mandates?
Where do you think the hedge fund industry is headed?
Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500 [more]
Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm.
Peter Turk is head of Opalesque Exclusive: New systematic strategy embraces machine learning [more]
Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares [more]
Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares
at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in
the healthcare services company to 15.16%, reported Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates [more]
Grayson’s hedge funds under scrutiny for possible ethics violations
From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite Hedge funds decline in June as stocks tumble on Greek woes [more]
From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent